Adolescent hypomania does not predict bipolar disorder

By Mark Cowen, Senior MedWire Reporter

Results from a Swedish study show that only a small proportion of depressed adolescents with hypomania spectrum episodes will develop bipolar disorder in adulthood.

In study of 64 individuals aged 16-17 years who screened positive for depression symptoms and lifetime hypomania spectrum symptoms, only six had experienced another hypomanic episode, or an episode or mania, by the age of 30-33 years.

"Thus, maintenance or prophylactic treatment does not seem warranted for this group," comment Päären Aivar (Uppsala University) and team in the Journal of Affective Disorders.

The findings come from a community-based study of 2300 adolescents who were screened for depression and hypomania between 1991 and 1993.

Of those who screened positive for depressive symptoms, 90 also screened positive for full syndromal hypomania lasting more than 4 days (n=40 [1.7%]), brief-episode hypomania lasting less than 4 days (n=18 [0.8%]), or subsyndromal hypomania (n=32 [1.4%]).

Of these, 64 participated in follow-up interviews after an average of 14 years.

The researchers found that just four (6%) of the participants interviewed at follow-up reported at least one episode of hypomania in adulthood, and just two (3%) reported at least one episode of mania.

In contrast, however, 38 (59%) met criteria for major depression at follow-up.

Aivar et al conclude: "The main message of this study is that a significant number of adolescents initially diagnosed with full-syndrome, brief-episode, and subsyndromal hypomania did not develop bipolar disorder as adults. However, a substantial proportion reported major depression later in life."

They add: "Our ability to recognize subjects with future bipolar disorder on the community level remains limited. Thus, long-term preventive or prophylactic pharmacological treatment in children with hypomania spectrum disorder might be risky.

"Reliable early identifiers of this heterogeneous disorder still remain to be detected."

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New technology for visualizing AMPA receptors offers insights into psychiatric disorders